Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Methylophiopogonanone A has anti-inflammatory and anti-oxidative properties. 2. Methylophiopogonanone A has therapeutic potential against cerebral I/R injury through its ability to attenuate BBB disruption by regulating the expression of MMP-9 and tight junction proteins.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 72.00 | |
5 mg | In stock | $ 168.00 | |
10 mg | In stock | $ 250.00 | |
25 mg | In stock | $ 418.00 | |
50 mg | In stock | $ 623.00 | |
100 mg | In stock | $ 887.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 190.00 |
Description | 1. Methylophiopogonanone A has anti-inflammatory and anti-oxidative properties. 2. Methylophiopogonanone A has therapeutic potential against cerebral I/R injury through its ability to attenuate BBB disruption by regulating the expression of MMP-9 and tight junction proteins. |
Source |
Molecular Weight | 342.34 |
Formula | C19H18O6 |
CAS No. | 74805-92-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/ml (175.26 mM)
Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Methylophiopogonanone A 74805-92-8 Others Inhibitor inhibit inhibitor